Daniel P. Hart

6.4k total citations · 3 hit papers
58 papers, 2.9k citations indexed

About

Daniel P. Hart is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Daniel P. Hart has authored 58 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Hematology, 14 papers in Genetics and 9 papers in Oncology. Recurrent topics in Daniel P. Hart's work include Hemophilia Treatment and Research (41 papers), Platelet Disorders and Treatments (20 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (12 papers). Daniel P. Hart is often cited by papers focused on Hemophilia Treatment and Research (41 papers), Platelet Disorders and Treatments (20 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (12 papers). Daniel P. Hart collaborates with scholars based in United Kingdom, United States and Sweden. Daniel P. Hart's co-authors include John Pasi, Sean Platton, Peter MacCallum, Peter W. Collins, C. R. M. Hay, Ross Davenport, Karim Brohi, Joanna Manson, Simon Stanworth and Savita Rangarajan and has published in prestigious journals such as New England Journal of Medicine, Blood and PLoS ONE.

In The Last Decade

Daniel P. Hart

57 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Functional definition and characterization of acute traumatic coagulopathy

2011 380 citations Ross Davenport, Joanna Manson et al. profile →
The incidence and magnitude of fibrinolytic activation in trauma patients

2012 344 citations Imran Raza, Ross Davenport et al. Journal of Thrombosis and Haemostasis profile →
Haemophilia

2021 178 citations Erik Berntorp, Kathelijn Fischer et al. Nature Reviews Disease Primers profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel P. Hart United Kingdom	26	1.5k	648	490	481	372	58	2.9k
W. Keith Hoots United States	34	2.5k 1.7×	224 0.3×	196 0.4×	150 0.3×	324 0.9×	97	4.2k
Werner Rabitsch Austria	32	1.5k 1.0×	119 0.2×	692 1.4×	234 0.5×	713 1.9×	135	3.0k
Maha Othman Canada	26	1.3k 0.9×	253 0.4×	166 0.3×	71 0.1×	275 0.7×	147	2.5k
Lynne Uhl United States	23	829 0.6×	179 0.3×	327 0.7×	218 0.5×	861 2.3×	69	2.2k
W. Kreuz Germany	39	3.0k 2.1×	148 0.2×	150 0.3×	98 0.2×	415 1.1×	137	4.7k
Jan–Dirk Studt Switzerland	23	583 0.4×	140 0.2×	562 1.1×	97 0.2×	588 1.6×	65	2.8k
Erik A.M. Beckers Netherlands	26	1.2k 0.8×	346 0.5×	81 0.2×	104 0.2×	64 0.2×	92	2.2k
Katerina Pavenski Canada	21	970 0.7×	200 0.3×	78 0.2×	99 0.2×	1.0k 2.7×	103	2.2k
Howard F. Taswell United States	33	668 0.5×	246 0.4×	423 0.9×	65 0.1×	316 0.8×	105	3.4k
Christopher A. Tormey United States	25	1.4k 1.0×	246 0.4×	72 0.1×	70 0.1×	237 0.6×	155	2.3k

Countries citing papers authored by Daniel P. Hart

Since Specialization

Citations

This map shows the geographic impact of Daniel P. Hart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel P. Hart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel P. Hart more than expected).

Fields of papers citing papers by Daniel P. Hart

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel P. Hart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel P. Hart. The network helps show where Daniel P. Hart may publish in the future.

Co-authorship network of co-authors of Daniel P. Hart

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel P. Hart. A scholar is included among the top collaborators of Daniel P. Hart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel P. Hart. Daniel P. Hart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hart, Daniel P., et al.. (2023). A cohort study and matched pair analysis evaluating the effects of the COVID‐19 pandemic on access to dental care for people with inherited bleeding disorders. Haemophilia. 29(5). 1276–1282. 2 indexed citations

Kaczmarek, Radosław, Magdy El Ekiaby, Daniel P. Hart, et al.. (2021). Vaccination against COVID‐19: Rationale, modalities and precautions for patients with haemophilia and other inherited bleeding disorders. Haemophilia. 27(4). 515–518. 6 indexed citations

Hart, Daniel P., Jayanthi Alamelu, Neha Bhatnagar, et al.. (2021). Immune tolerance induction in severe haemophilia A: A UKHCDO inhibitor and paediatric working party consensus update. Haemophilia. 27(6). 932–937. 17 indexed citations

Hart, Daniel P., Brian R. Branchford, Sarah Hendry, et al.. (2021). Optimizing language for effective communication of gene therapy concepts with hemophilia patients: a qualitative study. Orphanet Journal of Rare Diseases. 16(1). 189–189. 20 indexed citations

Berntorp, Erik, Kathelijn Fischer, Daniel P. Hart, et al.. (2021). Haemophilia. Nature Reviews Disease Primers. 7(1). 45–45. 178 indexed citations breakdown →

Miesbach, Wolfgang, Pratima Chowdary, Michiel Coppens, et al.. (2021). Delivery of AAV‐based gene therapy through haemophilia centres—A need for re‐evaluation of infrastructure and comprehensive care: A Joint publication of EAHAD and EHC. Haemophilia. 27(6). 967–973. 42 indexed citations

Ryder, Nuala, et al.. (2020). Adherence to prophylaxis in adolescents and young adults with severe haemophilia: a qualitative study with healthcare professionals. Health Psychology and Behavioral Medicine. 8(1). 55–72. 1 indexed citations

Hart, Daniel P., et al.. (2018). Factor VIII cross-matches to the human proteome reduce the predicted inhibitor risk in missense mutation hemophilia A. Haematologica. 104(3). 599–608. 7 indexed citations

Liesner, Ri, Pratima Chowdary, Daniel P. Hart, et al.. (2018). Perioperative replacement therapy in haemophilia B: An appeal to “B” more precise. Haemophilia. 24(4). 611–618. 6 indexed citations

10.

Iorio, Alfonso, Andrea N. Edginton, Victor S. Blanchette, et al.. (2018). Performing and interpreting individual pharmacokinetic profiles in patients with Hemophilia A or B: Rationale and general considerations. Research and Practice in Thrombosis and Haemostasis. 2(3). 535–548. 45 indexed citations

11.

Hart, Daniel P., et al.. (2016). Anti-fibrinolytic agents in bleeding disorders – A clinical perspective. 3(2). 80–83. 3 indexed citations

12.

Kitchen, Steve, Kenneth D. Friedman, Daniel P. Hart, et al.. (2016). A computer‐based model to assess costs associated with the use of factor VIII and factor IX one‐stage and chromogenic activity assays. Journal of Thrombosis and Haemostasis. 14(4). 757–764. 29 indexed citations

13.

Batty, Paul, Gary Moore, Sean Platton, et al.. (2015). Diagnostic accuracy study of a factor VIII ELISA for detection of factor VIII antibodies in congenital and acquired haemophilia A. Thrombosis and Haemostasis. 114(10). 804–811. 19 indexed citations

14.

Collins, Peter W., Elizabeth Chalmers, Daniel P. Hart, et al.. (2014). Factor VIII brand and the incidence of factor VIII inhibitors in previously untreated UK children with severe hemophilia A, 2000-2011. Blood. 124(23). 3389–3397. 81 indexed citations

15.

Khair, Kate, Paul Batty, Louise Bowles, et al.. (2014). Wilate use in 47 children with von Willebrand disease: the North London paediatric haemophilia network experience. Haemophilia. 21(1). e44–50. 12 indexed citations

16.

Raza, Imran, Ross Davenport, C. P. Rourke, et al.. (2012). The incidence and magnitude of fibrinolytic activation in trauma patients. Journal of Thrombosis and Haemostasis. 11(2). 307–314. 344 indexed citations breakdown →

17.

Hart, Daniel P., Robert F. Miller, Simon Edwards, et al.. (2011). Human immunodeficiency virus associated thrombotic thrombocytopenic purpura – favourable outcome with plasma exchange and prompt initiation of highly active antiretroviral therapy. British Journal of Haematology. 153(4). 515–519. 44 indexed citations

18.

Perro, Mario, Julia Y. Tsang, David Escors, et al.. (2010). Generation of multi-functional antigen-specific human T-cells by lentiviral TCR gene transfer. Gene Therapy. 17(6). 721–732. 32 indexed citations

19.

Gao, Lina, Simone Thomas, Daniel P. Hart, et al.. (2009). Development of a Wilms' tumor antigen-specific T-cell receptor for clinical trials: engineered patient's T cells can eliminate autologous leukemia blasts in NOD/SCID mice. Haematologica. 95(1). 126–134. 50 indexed citations

20.

Briggs, Carol, Daniel P. Hart, S. Kunka, Shinichiro Oguni, & S. J. Machin. (2006). Immature platelet fraction measurement: a future guide to platelet transfusion requirement after haematopoietic stem cell transplantation. Transfusion Medicine. 16(2). 101–109. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact